Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 1 2Phase 4 1Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Hodgkin Disease 35Lymphoma 18Urinary Bladder Neoplasms 10Neoplasms 3Melanoma 3Leukemia 2HIV Infections 2Glioma 2Carcinoma, Renal Cell 2Breast Neoplasms 2Urothelial Carcinoma of the Bladder 1Urethral Neoplasms 1Ureteral Neoplasms 1Survival Without Progression 1Skin Neoplasms 1Sarcoma 1Rhabdoid Tumor 1Recurrence 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pathologic Complete Response 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neuroectodermal Tumors, Primitive, Peripheral 1Mesothelioma, Malignant 1Lymphoma, Large-Cell, Anaplastic 1Lung Neoplasms 1Kidney Neoplasms 1Desmoid Tumors 1

Interventions

Carboplatin 359Pemetrexed 275Cisplatin 229Paclitaxel 212Docetaxel 205Gemcitabine 160Erlotinib Hydrochloride 150Bevacizumab 132pembrolizumab 128Radiotherapy 112Nivolumab 88durvalumab 84Drug Therapy 84osimertinib 81atezolizumab 58Vinorelbine 53Gefitinib 53Radiosurgery 49Cetuximab 39Taxes 37130-nm albumin-bound paclitaxel 36Ipilimumab 34anlotinib 33Surgical Procedures, Operative 33Magnetic Resonance Spectroscopy 33Etoposide 30Albumin-Bound Paclitaxel 29tislelizumab 27icotinib 27Specimen Handling 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Carcinoma, Non-Small-Cell Lung × Vinblastine × Clear all
NCT00083083 2011-03-01

Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
250 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡